Smoking, life expectancy, and chronic disease in South Korea, Singapore, and the United States: A microsimulation model

Full metadata record

DC FieldValue
dc.contributor.authorDaejung Kim
dc.contributor.authorCynthia Chen
dc.contributor.authorBryan Tysinger
dc.contributor.authorSungchul Park
dc.contributor.authorMing Zhe Chong
dc.contributor.authorLijia Wang
dc.contributor.authorMichelle Zhao
dc.contributor.authorJian‐Min Yuan
dc.contributor.authorWoon‐Puay Koh
dc.contributor.authorJoanne Yoong
dc.contributor.authorJay Bhattacharya
dc.contributor.authorKaren Eggleston
dc.date.accessioned2021-02-17T05:11:20Z
dc.date.available2021-02-17T05:11:20Z
dc.date.issued2020-12-04
dc.identifier.issn1057-9230
dc.identifier.urihttp://repository.kihasa.re.kr/handle/201002/37043
dc.description.abstractThe substantial social and economic burden attributable to smoking is well‐known, with heavy smokers at higher risk of chronic disease and premature mortality than light smokers and nonsmokers. In aging societies with high rates of male smoking such as in East Asia, smoking is a leading preventable risk factor for extending lives (including work‐lives) and healthy aging. However, little is known about whether smoking interventions targeted at heavy smokers relative to light smokers lead to disproportionately larger improvements in life expectancy and prevalence of chronic diseases and how the effects vary across populations. Using a microsimulation model, we examined the health effects of smoking reduction by simulating an elimination of smoking among subgroups of smokers in South Korea, Singapore, and the United States. We found that life expectancy would increase by 0.2 to 1.5 years among light smokers and 2.5 to 3.7 years among heavy smokers. Whereas both interventions led to an increased life expectancy and decreased the prevalence of chronic diseases in all three countries, the life‐extension benefits were greatest for those who would otherwise have been heavy smokers. Our findings illustrate how smoking interventions may have significant economic and social benefits, especially for life extension, that vary across countries.
dc.languageeng
dc.publisherWiley
dc.titleSmoking, life expectancy, and chronic disease in South Korea, Singapore, and the United States: A microsimulation model
dc.typeArticle
dc.type.localArticle(Academic)
dc.subject.keywordhealthy aging
dc.subject.keywordheavy smokers
dc.subject.keywordmicrosimulation
dc.subject.keywordSingapore
dc.subject.keywordsmoking interventions
dc.subject.keywordSouth Korea
dc.subject.keywordtobacco control
dc.subject.keywordUnited States
dc.contributor.affiliatedAuthorDaejung Kim
dc.identifier.localIdKIHASA-5138
dc.citation.titleHealth Economics
dc.citation.numberspecial issue paper
dc.citation.date2020
dc.citation.startPage1
dc.citation.endPage13
dc.identifier.bibliographicCitationHealth Economics, no. special issue paper, pp. 1 - 13
Files in This Item:
There are no files associated with this item.
Loading...

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse